Seattle Genetics Reports First Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. SMCI
6. GOOGL
7. RTX
8. COF
9. TSLA
10. CRWV

Go back to Seattle Genetics Reports First Quarter 2020 Financial Results

Seattle Genetics (SGEN) Misses Q1 EPS by 19c, Revenues Miss; Maintains FY20 Sales Outlook

April 30, 2020 4:53 PM EDT

Seattle Genetics (NASDAQ: SGEN) reported Q1 EPS of ($0.98), $0.19 worse than the analyst estimate of ($0.79). Revenue for the quarter came in at $198.51 million versus the consensus estimate of $207.14 million.

We have had a remarkable start to 2020, delivering record product sales in the first quarter that are now coming from both ADCETRIS and PADCEV. Notably,... More